Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.79	77.71	76.34
Graham Fair Price	15.18	16.51	14.33
PEG	-92.29	0.69	-8.91
Price/Book	-2.08	11.10	11.34
Price/Cash Flow	-34.66	92.09	-140.94
Prices/Earnings	-35.09	28.55	43.98
Price/Sales	-13.94	15.54	18.06
Price/FCF	-34.66	92.09	-140.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.25	0.31	0.29
Operating Margin	16.62	0.22	0.19
ROA	37.38	0.01	< 0.005
ROE	0.06	0.10	50.84
ROIC	0.01	0.02	20.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.02	-22.05
Dividends QOQ	2.00	95.62	4671.46
EBIT QOQ	-0.05	0.23	319.51
EPS QOQ	-0.05	0.42	741.56
FCF QOQ	0.20	2.39	1113.66
Revenue QOQ	-0.02	0.05	168.12
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.38	0.00	inf
Days Sales Outstanding (DSO)	19.16	17.52	-8.60
Inventory Turnover	5.18	0.00	inf
Debt/Capitalization	0.84	0.86	1.45
Quick Ratio	0.35	0.40	15.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.90	11.16	-6.22
Cash	1.92	3.00	55.71
Capex	-2.38	-2.09	11.94
Free Cash Flow	-0.96	1.35	40.54
Revenue	7.47	7.97	6.71
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.53	0.50	-6.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.16	26.33	8.98
Naive Interpretation	Member

06 - Financial Health · Bad

Rating